Status:
RECRUITING
A Machine Learning Approach for Predicting tDCS Treatment Outcomes of Adolescents With Autism Spectrum Disorders
Lead Sponsor:
The Hong Kong Polytechnic University
Collaborating Sponsors:
Chinese University of Hong Kong
Conditions:
Transcranial Direct Current Stimulation
Autistic Disorders Spectrum
Eligibility:
All Genders
12-22 years
Phase:
NA
Brief Summary
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by disturbances in communication, poor social skills, and aberrant behaviors. Particularly detrimental are the presence of...
Eligibility Criteria
Inclusion Criteria:
- Individuals who are confirmed by a clinical psychologist based on the Diagnostic and Statistical Manual of Mental Disorders-5th Ed (DSM-V) criteria of Autism spectrum disorder and structured interview with their parents or primary caregivers on their developmental history using the Autism Diagnostic Interview-Revised (ADI-R).
- Individuals with intelligence quotient above 60.
- Individuals who demonstrate the ability to comprehend testing and stimulation instructions.
Exclusion Criteria:
- Individuals with severe motor dysfunctions that would hinder their participation, and those with history of other neurological and psychiatric disorders and head trauma, or on psychiatric medication will be excluded from the study
Key Trial Info
Start Date :
January 5 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT05035511
Start Date
January 5 2022
End Date
June 30 2026
Last Update
February 6 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Hong Kong Polytechnic University
Hung Hom, Kowloon, Hong Kong